Figure 1From: Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasisType 1 T cells (IFN-γ producing) are decreased with alefacept therapy. Intracellular cytokine FACS detection of mean number of TNF-α, IL-2 and IFN-γ cells/ml, which are significantly decreased with therapy, P value indicated.Back to article page